HB-EGF protects the lungs after intestinal ischemia/reperfusion injury.

Acute respiratory distress syndrome continues to be a major source of morbidity and mortality in critically-ill patients. Heparin binding EGF-like growth factor (HB-EGF) is a biologically active protein that acts as an intestinal cytoprotective agent. We have previously demonstrated that HB-EGF protects the intestines from injury in several different animal models of intestinal injury. In the current study, we investigated the ability of HB-EGF to protect the lungs from remote organ injury after intestinal ischemia/reperfusion (I/R).
Mice were randomly assigned to one of the following groups: (1) sham-operated; (2) sham+HB-EGF (1200 microg/kg in 0.6 mL administered by intra-luminal injection at the jejuno-ileal junction immediately after identification of the superior mesenteric artery); (3) superior mesenteric artery occlusion for 45 min followed by reperfusion for 6 h (I/R); or (4) I/R+HB-EGF (1200 microg/kg in 0.6 mL) administered 15 min after vascular occlusion. The severity of acute lung injury was determined by histology, morphometric analysis and invasive pulmonary function testing. Animal survival was evaluated using Kaplan-Meier analysis.
Mice subjected to intestinal I/R injury showed histologic and functional evidence of acute lung injury and decreased survival compared with sham-operated animals. Compared with mice treated with HB-EGF (I/R+HB-EGF), the I/R group had more severe acute lung injury, and decreased survival.
Our results demonstrate that HB-EGF reduces the severity of acute lung injury after intestinal I/R in mice. These data demonstrate that HB-EGF may be a potential novel systemic anti-inflammatory agent for the prevention of the systemic inflammatory response syndrome (SIRS) after intestinal injury.
AuthorsIyore A O James, Chun-Liang Chen, Guangcun Huang, Hong-Yi Zhang, Markus Velten, Gail E Besner
JournalThe Journal of surgical research (J Surg Res) Vol. 163 Issue 1 Pg. 86-95 (Sep 2010) ISSN: 1095-8673 [Electronic] United States
PMID20599214 (Publication Type: Journal Article)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Hbegf protein, mouse
  • Heparin-binding EGF-like Growth Factor
  • Intercellular Signaling Peptides and Proteins
  • Proto-Oncogene Proteins c-akt
  • Animals
  • Apoptosis (drug effects)
  • Capillary Permeability (drug effects)
  • Heparin-binding EGF-like Growth Factor
  • Intercellular Signaling Peptides and Proteins (pharmacology, therapeutic use)
  • Intestine, Small (blood supply)
  • Lung (blood supply, drug effects)
  • Lung Injury (etiology, metabolism, prevention & control)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neutrophil Infiltration (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Pulmonary Diffusing Capacity (drug effects)
  • Reperfusion Injury (complications)
  • Respiratory Function Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: